Hassabis AI drug firm Isomorphic raises $5 billion
CNBC · RSS · · AI-summarised by FinFlash
Isomorphic Labs, the AI drug-discovery company led by Demis Hassabis, has raised $5 billion, months after he stepped down as chief executive of Google DeepMind. The company is looking to develop new medicines using artificial intelligence. The size of the raise signals continued investor appetite for AI-driven biotech despite heavy capital requirements.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.